Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy

Clinical trial NCT00306150 · TERMINATED

Trial details

NCT number: NCT00306150
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Blood Loss, Surgical Postoperative Hemorrhage

Start date: 2005-12-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.